pseudomyxoma peritonei

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

Peritoneal Carcinomatosis, Pseudomyxoma Peritonei, Mesothelioma Peritoneum Trial in Montpellier (Cardiac coherence, Standard

Recruiting
  • Peritoneal Carcinomatosis
  • +2 more
  • Cardiac coherence
  • Standard care
  • Montpellier, Hérault, France
    ICM
Jan 16, 2023

Severe Neutropenia After HIPEC Using Mitomycin-C

Recruiting
  • Colorectal Cancer Metastatic
  • +3 more
  • Intraoperative blood and peritoneal fluid samplings during HIPEC
  • Seoul, Korea, Republic of
    Division of Colon and Rectal Surgery, Department of Surgery, Gan
Aug 21, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • +11 more
  • Los Angeles, California
  • +16 more
Aug 15, 2022

Pseudomyxoma Peritonei Trial in Córdoba (Bromelin, N-Acetylcysteine)

Active, not recruiting
  • Pseudomyxoma Peritonei
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
Jun 1, 2022

Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)

Completed
  • Peritoneal Cancer
  • +7 more
  • nanoliposomal irinotecan
  • Lexington, Kentucky
  • +1 more
May 5, 2022

Pseudomyxoma Peritonei Trial in Milano (Capecitabine)

Recruiting
  • Pseudomyxoma Peritonei
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022

Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology

Not yet recruiting
  • Pseudomyxoma Peritonei
  • +3 more
  • (no location specified)
Feb 28, 2022

Register With Which Hyperthermic Intra-Peritoneal Chemotherapy

Recruiting
  • Peritoneal Carcinomatosis
  • +2 more
    • Leuven, Flemish Brabant, Belgium
      University Clinics Gasthuisberg
    Oct 14, 2021

    Pseudomyxoma Peritonei, Appendiceal Tumor, Cancer, Appendiceal Trial in Baltimore (Bio-specimen collection, Questionnaire)

    Recruiting
    • Pseudomyxoma Peritonei
    • +2 more
    • Bio-specimen collection
    • Questionnaire
    • Baltimore, Maryland
      Mercy Medical Center
    Sep 15, 2021

    Pseudomyxoma Peritonei, Colorectal Carcinoma, Ovarian Carcinoma Trial in Oslo (Observational study.)

    Recruiting
    • Pseudomyxoma Peritonei
    • +3 more
    • Observational study.
    • Oslo, Norway
      The Norwegian Radium Hospital
    Jul 21, 2021

    Peritoneal Carcinomatosis, Colorectal Cancer, Appendiceal Cancer Trial in Bronx (HIPEC, Mitomycin C)

    Completed
    • Peritoneal Carcinomatosis
    • +5 more
    • HIPEC
    • Mitomycin C
    • Bronx, New York
      Department of Surgery, Montefiore Medical Center- Weiler Divisio
    Jan 7, 2021

    Pseudomyxoma Peritonei, Appendiceal Tumors Trial in Baltimore (PrevPac (Prevacid, Amoxicillin, Clarithromycin))

    Active, not recruiting
    • Pseudomyxoma Peritonei
    • Appendiceal Neoplasms
    • PrevPac (Prevacid, Amoxicillin, Clarithromycin)
    • Baltimore, Maryland
      Mercy Medical Center
    Apr 1, 2020

    Patients With Pseudomyxoma Peritonei?

    Withdrawn
    • Pseudomyxoma Peritonei
    • +2 more
      • Basingstoke, Hampshire, United Kingdom
        Basingstoke and North Hampshire Hospital
      Jan 29, 2020

      Peritoneum Cancer, Peritoneum Tumor, Pleural Cancer Trial in Worldwide (PIPAC)

      Recruiting
      • Peritoneum Cancer
      • +14 more
      • PIPAC
      • Buenos Aires, Argentina
      • +15 more
      Oct 7, 2019

      Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma Trial in Winston-Salem (HIPEC Orientation,

      Completed
      • Advanced Malignant Mesothelioma
      • +15 more
      • HIPEC Orientation
      • +2 more
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Jul 2, 2018

      Pseudomyxoma Peritonei, Colorectal Cancer Trial in Milano (Cytoreductive surgery, Low Intra abdominal pressure HIPEC, High Intra

      Completed
      • Pseudomyxoma Peritonei
      • Colorectal Cancer
      • Cytoreductive surgery
      • +2 more
      • Milano, MI, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
      Feb 21, 2018

      Rare Peritoneal Surface Malignancies, Pseudomyxoma Peritonei, Peritoneal Mesothelioma Trial in France (Non interventional)

      Unknown status
      • Rare Peritoneal Surface Malignancies
      • +7 more
      • Non interventional
      • Angers, France
      • +32 more
      Aug 18, 2017

      Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition

      Completed
      • Pseudomyxoma Peritonei
      • +6 more
        • Naperville, Illinois
          Edward Hospital
        Feb 6, 2017

        Thrombin Generation and Platelet Activation in CRS/HIPEC

        Completed
        • Mesothelioma; Peritoneum
        • +2 more
        • CRS/HIPEC
        • (no location specified)
        Jan 24, 2017

        Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)

        Completed
        • Anxiety Disorder
        • +19 more
        • questionnaire administration
        • +5 more
        • Columbus, Ohio
          Ohio State University Medical Center
        Oct 8, 2015

        Results of CRS and Debulking in PMP Patients

        Unknown status
        • Pseudomyxoma Peritonei
          • (no location specified)
          Aug 31, 2011